Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice
✍ Scribed by Peggy A. Wentworth; Antonella Vitiello; John Sidney; Elissa Keogh; Robert W. Chesnut; Howard Grey; Alessandro Sette
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 547 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We have previously reported the production of a new monoclonal antibody (MAb) (SP-2) recognizing a 90-kDa tumorassociated antigen, termed 9OK. which is increased in the serum of many cancer patients. Treatment of CG5 human breast cancer cells with recombinant interferon-a 2b (rlFN-a 2b) can increase
Glucuronidation, an important bile acid detoxification pathway, is catalyzed by enzymes belonging to the UDP-glucuronosyltransferase (UGT) family. Among UGT enzymes, UGT1A3 is considered the major human enzyme for the hepatic C24-glucuronidation of the primary chenodeoxycholic (CDCA) and secondary l
## Communicated by Richard G.H. Cotton Interindividual differences in human CYP1A1 and CYP1A2 expression appear to be associated with variability in risk toward various types of environmental toxicity and cancer. These two genes are oriented head-to-head on human chromosome 15; the 23.3-kb spacer
## Abstract The syngeneic cytotoxic T‐cell response against a metastasizing murine lymphoma variant was investigated and compared with the response against the non‐metastasizing parental tumor line Eb. Anti‐tumor cytotoxicity was not detectable in a 4‐h ^51^Cr release assay in spleens taken directl